{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T04:29:31Z","timestamp":1793852971854,"version":"4.6.1"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007334","name":"Ministry of Health and Family Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007334","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.vaccine.2025.127787","type":"journal-article","created":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T21:06:19Z","timestamp":1759007179000},"page":"127787","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Immunogenicity of the abbreviated one-week intradermal rabies pre-exposure prophylaxis and its boostability in health-care workers: A retrospective observational cohort study"],"prefix":"10.1016","volume":"65","author":[{"given":"M.A.","family":"Ashwini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shipra","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lonika","family":"Lodha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arya","family":"Ramachandran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amrita","family":"Pattanaik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.S.","family":"Sujatha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reeta S.","family":"Mani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2025.127787_bb0005","doi-asserted-by":"crossref","first-page":"5500","DOI":"10.1016\/j.vaccine.2018.06.061","article-title":"Rabies vaccines: WHO position paper, April 2018 \u2013 Recommendations","volume":"36","author":"World Health Organization","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.127787_bb0010","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1093\/cid\/ciy513","article-title":"Preexposure intradermal rabies vaccination: a noninferiority trial in healthy adults on shortening the vaccination schedule from 28 to 7 days","volume":"68","author":"Soentjens","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2025.127787_bb0015","first-page":"29","article-title":"Long-term persistence of antibodies and boostability after rabies intradermal pre-exposure prophylaxis","author":"Mills","year":"2022","journal-title":"J Travel Med"},{"key":"10.1016\/j.vaccine.2025.127787_bb0020","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1708-8305.2007.00120.x","article-title":"Immunogenicity study of abbreviated rabies Preexposure vaccination schedules: table 1","volume":"14","author":"Khawplod","year":"2007","journal-title":"J Travel Med"},{"key":"10.1016\/j.vaccine.2025.127787_bb0025","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1708-8305.2011.00540.x","article-title":"The immunogenicity of a modified intradermal pre-exposure rabies vaccination schedule\u2014a case series of 420 travelers","volume":"18","author":"Mills","year":"2011","journal-title":"J Travel Med"},{"key":"10.1016\/j.vaccine.2025.127787_bb0030","doi-asserted-by":"crossref","DOI":"10.1093\/jtm\/taz021","article-title":"Revised recommendations for rabies pre-exposure prophylaxis in travellers: avoid bumpy roads, select the highway!","author":"Knopf","year":"2019","journal-title":"J Travel Med"},{"key":"10.1016\/j.vaccine.2025.127787_bb0035","first-page":"27","article-title":"Intradermal rabies pre-exposure vaccination schedules in older travellers: comparison of immunogenicity post-primary course and post-booster","author":"Furuya-Kanamori","year":"2020","journal-title":"J Travel Med"},{"key":"10.1016\/j.vaccine.2025.127787_bb0040","doi-asserted-by":"crossref","first-page":"5347","DOI":"10.1016\/j.vaccine.2022.07.037","volume":"40","author":"Quiambao","year":"2022","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.127787_bb0045","article-title":"Noninferiority study of purified Vero rabies vaccine\u2014serum free in 3-dose and 2-dose Preexposure prophylaxis regimens in comparison with licensed rabies vaccines","author":"Chokephaibulkit","year":"2024","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2025.127787_bb0050","doi-asserted-by":"crossref","first-page":"120","DOI":"10.4161\/hv.26456","article-title":"Safety and immunogenicity study of a new purified chick embryo cell rabies vaccine Vaxirab-N (pitman\u2013Moore strain) manufactured in India","volume":"10","author":"Ashwath Narayana","year":"2014","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2025.127787_bb0055","series-title":"Laboratory techniques in rabies","author":"Rupprecht","year":"2018"},{"key":"10.1016\/j.vaccine.2025.127787_bb0060","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.3390\/v13071252","article-title":"The route of Administration of Rabies Vaccines: comparing the data","volume":"13","author":"Briggs","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.vaccine.2025.127787_bb0065","doi-asserted-by":"crossref","first-page":"619","DOI":"10.15585\/mmwr.mm7118a2","article-title":"Use of a modified Preexposure prophylaxis vaccination schedule to prevent human rabies: recommendations of the advisory committee on immunization practices \u2014 United States, 2022","volume":"71","author":"Rao","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2025.127787_bb0070","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.tmaid.2018.03.006","article-title":"Rabies antibody response after two intradermal pre-exposure prophylaxis immunizations: an observational cohort study","volume":"22","author":"De Pijper","year":"2018","journal-title":"Travel Med Infect Dis"},{"key":"10.1016\/j.vaccine.2025.127787_bb0075","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/avj.12692","article-title":"Survey of rabies vaccination status of Queensland veterinarians and veterinary students","volume":"96","author":"Mendez","year":"2018","journal-title":"Aust Vet J"},{"key":"10.1016\/j.vaccine.2025.127787_bb0080","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.2460\/javma.252.12.1491","article-title":"Rabies exposures and pre-exposure vaccination practices among individuals with an increased risk of rabies exposure in the United States","volume":"252","author":"Blanton","year":"2018","journal-title":"J Am Vet Med Assoc"},{"key":"10.1016\/j.vaccine.2025.127787_bb0085","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/zph.12568","article-title":"Challenges to human rabies elimination highlighted following a rabies outbreak in bovines and a human in Punjab, India","volume":"66","author":"Brookes","year":"2019","journal-title":"Zoonoses Public Health"},{"key":"10.1016\/j.vaccine.2025.127787_bb0090","doi-asserted-by":"crossref","first-page":"561","DOI":"10.7589\/JWD-D-20-00044","article-title":"Exposure of wild boar (Sus scrofa) to the common vampire bat and lack of immune protection to rabies virus in brazilian hunters","volume":"57","author":"Teider-Junior","year":"2021","journal-title":"J Wildl Dis"},{"key":"10.1016\/j.vaccine.2025.127787_bb0095","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s10393-017-1208-2","article-title":"Occupational risks and exposures among wildlife health professionals","volume":"14","author":"Garland-Lewis","year":"2017","journal-title":"Ecohealth"},{"key":"10.1016\/j.vaccine.2025.127787_bb0100","doi-asserted-by":"crossref","first-page":"691","DOI":"10.31729\/jnma.3630","article-title":"Health problems while working as a volunteer or humanitarian aid worker in post-earthquake Nepal","volume":"56","author":"Bhandari","year":"2018","journal-title":"JNMA J Nepal Med Assoc"},{"key":"10.1016\/j.vaccine.2025.127787_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2024.126703","article-title":"Routine childhood rabies pre-exposure prophylaxis can be cost effective in low- and middle-income countries","volume":"47","author":"Ritchie","year":"2025","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25010849?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25010849?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T07:37:35Z","timestamp":1765870655000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X25010849"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":21,"alternative-id":["S0264410X25010849"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.127787","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunogenicity of the abbreviated one-week intradermal rabies pre-exposure prophylaxis and its boostability in health-care workers: A retrospective observational cohort study","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.127787","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"127787"}}